Nieuws en video's - ABATTIS BIOCEUTICALS ATTBF

Abattis Announces Acquisition of European Nutraceutical Company and Provides Corporate Updates PR Newswire VANCOUVER, British Columbia, April 2, 2019 VANCOUVER, British Columbia , April 2, 2019 /PRNewswire/ -- Abattis Bioceuticals Corp. (the " Company " or " Abattis ") (CSE: ATT) (OTC: ATTBF) is pleased to announce that its wholly-owned subsidiary, 1185277 B .C. Ltd. (the " Acquisition Subsidiary "), has entered into a share purchase agreement (the " Agreement ") to acquire (the " Acquisition ")...

Abattis Announces Acquisition of European Nutraceutical Company and Provides Corporate Updates PR Newswire VANCOUVER, British Columbia, April 2, 2019 VANCOUVER, British Columbia , April 2, 2019 /PRNewswire/ -- Abattis Bioceuticals Corp. (the " Company " or " Abattis ") (CSE: ATT) (OTC: ATTBF) is pleased to announce that its wholly-owned subsidiary, 1185277 B .C. Ltd. (the " Acquisition Subsidiary "), has entered into a share purchase agreement (the " Agreement ") to acquire (the " Acquisition ")...

Vancouver, British Columbia--(Newsfile Corp. - March 9, 2019) - Abattis Bioceuticals Corp (CSE: ATT) (OTC Pink: ATTBF) (the " Company " or " Abattis ") announces that, effective February 20, 2019 and March 6, 2019, both Wolfgang Richter and James Irving have respectively resigned as directors of the Company. The Company thanks both Mr. Richter and Mr. Irving for their service and wishes each all the best in their future endeavors. About Abattis Bioceuticals Corp. Abattis is positioned to be a...

Vergence Naturals and Naturopathic Doctor and Nutraceutical Product Developer Brazos Minshew Launch Comfort PR Newswire VANCOUVER, British Columbia, Dec. 18, 2018 VANCOUVER, British Columbia , Dec. 18, 2018 /PRNewswire/ -- Abattis Bioceuticals Corp (the " Company " or " Abattis ") (CSE:ATT) (OTC:ATTBF) is pleased to announce its first proprietary product, Comfort, which has been produced through wholly owned subsidiary Vergence Naturals (" Vergence "). Abattis has teamed up with respected...

Abattis Bioceuticals Signs National Distribution Agreement With Shefield & Sons PR Newswire VANCOUVER, British Columbia, November 27, 2018 VANCOUVER, British Columbia , November 27, 2018 /PRNewswire/ -- Abattis Bioceuticals Corp (the " Company " or " Abattis ") (CSE: ATT) (OTC: ATTBF) is pleased to announce that the Company has signed a Distribution Agreement (the " Distribution Agreement ") with Shefield & Sons Tobacconists Inc. (" Shefield & Sons ") to sell the Abattis vaporizer line in all...

SEATTLE, Oct. 30, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering the launch of Abattis Bioceuticals Corp.'s (CSE: ATT) (OTC: ATTBF) latest product innovation. “Comfort”, a nutraceutical designed to alleviate chronic pain and inflammation, is the first in line of a dozen new products the company expects to launch over 36 months. According...

Vancouver, British Columbia--(Newsfile Corp. - October 19, 2018) - Abattis Bioceuticals Corp . (CSE: ATT) (OTC Pink: ATTBF) (the " Company " or " Abattis ") is pleased to announce the additions of Kent McParland and Cedric Wilson to the Board of Directors (the " Board "). Mr. McParland and Mr. Wilson replace Cameron Paddock and Rene David who have left Abattis to concentrate on other ventures. Mr. McParland is a Chartered Professional Accountant experienced in multiple industries and...

Vancouver, British Columbia--(Newsfile Corp. - April 30, 2018) - Abattis Bioceuticals Corp. (the " Company " or " Abattis ") (CSE: ATT / OTC: ATTBF) is pleased to announce, further to its news release dated April 18, 2018, that it has completed its acquisition of the remaining 10% ownership interest (the " Interest ") in its subsidiary, Gabriola Green Farms Inc. (" Gabriola "). Abattis acquired the Interest from CannaNUMUS Blockchain Inc. for $2.5 million. Gabriola is now a wholly-owned...

Vancouver, British Columbia--(Newsfile Corp. - April 18, 2018) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the " Company " or " Abattis ") is pleased to announce that it has entered into a share purchase agreement to acquire (the " Acquisition ") the remaining 10% ownership interest in its subsidiary, Gabriola Green Farms Inc. (" G abriola "). "We are very happy to now own a 100% interest in Gabriola and integrate it as a wholly-owned subsidiary of Abattis. We believe that Gabriola's...

Vancouver, British Columbia--(Newsfile Corp. - April 13, 2018) - Abattis Bioceuticals Corp. (the " Company " or " Abattis ") (CSE: ATT) (OTCQB: ATTBF) is pleased to announce the addition of Cameron Paddock to the Board of Directors. Mr. Paddock will fill the vacancy left by the resignation of Dr. Will Panenka who is leaving the Company to concentrate on other ventures. "We are very excited have Mr. Paddock join our Board. On behalf of the Company, I would like to thank Dr. Panenka for his...

Vancouver, British Columbia--(Newsfile Corp. - March 26, 2018) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the " Company " or " Abattis ") announces a correction to its news release dated March 13, 2018 (the " Release "). In the Release, Canadian Artesian Ice Ltd. (" Canadian Artesian ") was described as being the bottlers of Clearly Canadian products. However, the Company has since been advised that Canadian Artesian are not the bottlers of Clearly Canadian products. About Abattis...

Abattis Signs LOI With Kanabé to Provide a Full Suite of Downstream Cannabis Solutions to Their Premium Health and Wellness Products PR Newswire VANCOUVER, British Columbia, March 8, 2018 VANCOUVER, British Columbia , March 8, 2018 /PRNewswire/ -- Abattis Bioceuticals Corp. (the " Company " or " Abattis ") (CSE: ATT) (OTC: ATTBF) is pleased to announce it has signed a letter of intent (the " LOI ") with Kanabé Corp. (" Kanabé ") to provide Kanabé with cannabinoids as well as formulation,...

DGAP-News: Abattis Bioceuticals Corp. / Key word(s): Miscellaneous Abattis Comments on Recent Market Activity 02.03.2018 / 02:02 The issuer is solely responsible for the content of this announcement. Vancouver, British Columbia--(Newsfile Corp. - March 1, 2018) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the ' Company ' or ' Abattis '), wishes to make the following statements regarding certain market activity surrounding the Company's common shares (the ' Common Shares '). On...

Vancouver, British Columbia--(Newsfile Corp. - March 1, 2018) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the " Company " or " Abattis "), wishes to make the following statements regarding certain market activity surrounding the Company's common shares (the " Common Shares "). On February 27, 2018, the Company was notified by the OTC Markets about certain promotional activities in relation to the Common Shares, including certain newsletter emails. The Company engaged Awareness...

Abattis Enters Into Definitive Agreement To Acquire Gabriola Green Farms PR Newswire VANCOUVER, British Columbia, February 27, 2018 VANCOUVER, British Columbia , February 27, 2018 /PRNewswire/ -- Abattis Bioceuticals Corp. (the " Company " or " Abattis ") ( CSE : ATT) (CSE: ATT.CN) (OTC: ATTBF) is pleased to announce that it has entered into a definitive agreement (the " Definitive Agreement ") to acquire (the " Acquisition ") a 90% ownership interest in Gabriola Green Farms Inc. (" Gabriola ")....

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2018) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the "Company" or "Abattis") is pleased to announce that, along with Northern Vine Labs, it will be attending the Lift Cannabis Expo, Canada's largest and best-attended cannabis tradeshow, from January 12 to 14 at the Vancouver Convention Centre. This year's Lift Expo will feature nearly 200 exhibitors from across North America and will host talks by cannabis thought leaders,...

Vancouver, British Columbia--(Newsfile Corp. - January 10, 2018) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the " Company " or " Abattis ") is pleased to announce that, further to its news release dated January 4, 2018, it has successfully closed its non-brokered private placement of units (each, a " Unit ") for gross proceeds of $6.9 million (the " Private Placement "). "Abattis has once again oversubscribed its private placement," said Rob Abenante, President and CEO of Abattis....

Vancouver, British Columbia--(Newsfile Corp. - January 4, 2018) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the " Company " or " Abattis ") is pleased to announce that, further to its news releases dated December 15 and December 19, 2017, it has completed the second and final tranche of its non-brokered private placement of units (each, a " Unit ") for gross proceeds of $6.7 million (the " Private Placement "). "The Company continues to see overwhelming demand for its private...

DGAP-News: Abattis Bioceuticals Corp. / Key word(s): Miscellaneous Abattis Announces Letter of Intent to Acquire Winston Resources 22.12.2017 / 15:28 The issuer is solely responsible for the content of this announcement. Vancouver, British Columbia--(Newsfile Corp. - December 22, 2017) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the ' Company ' or ' Abattis ') is pleased to announce that, effective today, it has entered into a non-binding letter of intent (the ' LOI ') with Winston...

Vancouver, British Columbia--(Newsfile Corp. - December 22, 2017) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the " Company " or " Abattis ") is pleased to announce that, effective today, it has entered into a non-binding letter of intent (the " LOI ") with Winston Resources Inc. (" Winston Resources "), a reporting issuer listed on the Canadian Securities Exchange, which outlines the general terms and conditions of a proposed transaction (the " Proposed Transaction ") that will...